UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Schwarz Dygos Wheeler Investment Advisors LLC

Schwarz Dygos Wheeler Investment Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,808 shares of the healthcare conglomerate’s stock after selling 567 shares during the period. UnitedHealth Group accounts for about 1.5% of Schwarz Dygos Wheeler Investment Advisors LLC’s portfolio, making the stock its 11th largest holding. Schwarz Dygos Wheeler Investment Advisors LLC’s holdings in UnitedHealth Group were worth $6,185,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. GAMMA Investing LLC increased its position in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares during the period. Northern Trust Corp increased its position in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares during the period. Finally, Capital International Investors increased its position in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.2%

Shares of UnitedHealth Group stock opened at $300.37 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $272.48 billion, a PE ratio of 12.58, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The company has a 50-day moving average of $312.43 and a two-hundred day moving average of $438.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the business earned $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.94%. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. HSBC restated a “reduce” rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $415.00.

Insider Transactions at UnitedHealth Group

In other news, Director Kristen Gil bought 3,700 shares of the stock in a transaction on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.